Clinical Trials in Salt Lake City

Showing 13981-14000 of 16,694 trials

Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1

NCT00655460

The Purpose of this study is to: 1. Refine and validate a computerized bedside decision support tool blood glucose management in critically ill adult and pediatric ICU patients. 2. Monitor how often low blood sugar levels occur during use of the bedside tool. 3. Determine how the computerized tool effects the workload of the ICU nurses.

Critically IllHyperglycemia

Intermountain Health Care, Inc.200 participantsStarted Feb 2006

New Haven, Connecticut, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Extension Study for 2993-112

NCT01789957

This multicenter, open-label extension study of Protocol 2993-112 is designed to assess long-term glucose control as measured by HbA1c (glycosylated hemoglobin) and to evaluate long-term safety and tolerability in subjects treated with metformin who receive subcutaneously injected AC2993 (10 mcg) administered twice daily. Subjects completing Protocol 2993-112 are eligible to enroll.

Type 2 Diabetes Mellitus

AstraZeneca225 participantsStarted Sep 2002

Anniston, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +223 more locations

Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1

Extension Study for 2993-112

Find Trials by Condition in Salt Lake City

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY